WD Bennett, KN Olivier, KL Zeman, KW Hohneker, RC Boucher and MR Knowles
Division of Pulmonary Diseases, Department of Medicine, University of North Carolina at Chapel Hill, USA.

Cystic fibrosis (CF) is characterized by abnormal airway epithelial electrolyte transport leading to viscous airway secretions that are difficult to clear. By enhancing Cl- secretion onto and blocking Na+ absorption from the airway surface, treatment with aerosolized uridine 5'-triphosphate (UTP) plus amiloride may improve the rheology of airway secretions and enhance mucociliary clearance in patients with CF. After performing safety studies of aerosolized UTP/amiloride in adult patients with CF, we investigated the effects of inhaled vehicle and UTP/amiloride on mucociliary clearance of [99mTc] iron oxide particles from the airways of adult patients with CF (n = 14). We found no clinically significant adverse effects from inhalation of therapeutic doses of UTP/amiloride. Mean baseline peripheral clearance rates during the first 40 min of clearance measurements were significantly less in patients with CF than in normal subjects (mean +/- SE: 0.30 +/- 0.05 versus 0.54 +/- 0.07%/min, respectively; p = 0.01). Aerosolized UTP and amiloride in combination improved mucociliary clearance from the peripheral airways of the CF lungs to near normal values (0.51 +/- 0.09%/min; p = 0.04) during this period. These data support the concept for the use of UTP in combination with amiloride as therapy to improve clearance of secretions from the lungs of patients with CF.

This article has been cited by other articles:

				R. R. Deterding, L. M. LaVange, J. M. Engels, D. W. Mathews, S. J. Coquillette, A. S. Brody, S. P. Millard, B. W. Ramsey, and for the Cystic Fibrosis Therapeutics Development N Phase 2 Randomized Safety and Efficacy Trial of Nebulized Denufosol Tetrasodium in Cystic Fibrosis Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 362 - 369. [Abstract] [Full Text] [PDF]

				S. H. Donaldson, T. E. Corcoran, B. L. Laube, and W. D. Bennett Mucociliary Clearance as an Outcome Measure for Cystic Fibrosis Clinical Research Proceedings of the ATS, August 1, 2007; 4(4): 399 - 405. [Abstract] [Full Text] [PDF]

				C. D. Douillet, W. P. Robinson III, P. M. Milano, R. C. Boucher, and P. B. Rich Nucleotides induce IL-6 release from human airway epithelia via P2Y2 and p38 MAPK-dependent pathways Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L734 - L746. [Abstract] [Full Text] [PDF]

				M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341. [Abstract] [Full Text] [PDF]

				T. E. Machen Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol, August 1, 2006; 291(2): C218 - C230. [Abstract] [Full Text] [PDF]

				V. Govindaraju, J. G. Martin, K. Maghni, P. Ferraro, and M.-C. Michoud The Effects of Extracellular Purines and Pyrimidines on Human Airway Smooth Muscle Cells J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 941 - 948. [Abstract] [Full Text] [PDF]

				A.-D. Qi, S. C. Wolff, and R. A. Nicholas The Apical Targeting Signal of the P2Y2 Receptor Is Located in Its First Extracellular Loop J. Biol. Chem., August 12, 2005; 280(32): 29169 - 29175. [Abstract] [Full Text] [PDF]

				M. Picher, L. H. Burch, and R. C. Boucher Metabolism of P2 Receptor Agonists in Human Airways: IMPLICATIONS FOR MUCOCILIARY CLEARANCE AND CYSTIC FIBROSIS J. Biol. Chem., May 7, 2004; 279(19): 20234 - 20241. [Abstract] [Full Text] [PDF]

				A. Zsembery, A. T. Boyce, L. Liang, J. Peti-Peterdi, P. D. Bell, and E. M. Schwiebert Sustained Calcium Entry through P2X Nucleotide Receptor Channels in Human Airway Epithelial Cells J. Biol. Chem., April 4, 2003; 278(15): 13398 - 13408. [Abstract] [Full Text] [PDF]

				M.-C. Michoud, G. Napolitano, K. Maghni, V. Govindaraju, A. Cogo, and J. G. Martin Effects of Extracellular Triphosphate Nucleotides and Nucleosides on Airway Smooth Muscle Cell Proliferation Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 732 - 738. [Abstract] [Full Text] [PDF]

				F. L. Johnson, J. F. Donohue, and C. L. Shaffer Improved Sputum Expectoration Following a Single Dose of INS316 in Patients With Chronic Bronchitis Chest, December 1, 2002; 122(6): 2021 - 2029. [Abstract] [Full Text] [PDF]

				C F Robertson How do we choose a therapeutic regimen in cystic fibrosis? Thorax, October 1, 2002; 57(10): 839 - 840. [Full Text] [PDF]

				S. H. Donaldson, M. Picher, and R. C. Boucher Secreted and Cell-Associated Adenylate Kinase and Nucleoside Diphosphokinase Contribute to Extracellular Nucleotide Metabolism on Human Airway Surfaces Am. J. Respir. Cell Mol. Biol., February 1, 2002; 26(2): 209 - 215. [Abstract] [Full Text] [PDF]

				J. TAMAOKI, M. KONDO, H. KURODA, K. AOSHIBA, K. TAKEYAMA, J. NAKATA, and A. NAGAI Validity and Safety of Sputum Induction by Inhaled Uridine 5'-Triphosphate Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 378 - 381. [Abstract] [Full Text] [PDF]

				H.C. Rodgers and A.J. Knox Pharmacological treatment of the biochemical defect in cystic fibrosis airways Eur. Respir. J., June 1, 2001; 17(6): 1314 - 1321. [Abstract] [Full Text] [PDF]

				D. M. Morse, J. L. Smullen, and C. W. Davis Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1485 - C1497. [Abstract] [Full Text] [PDF]

				M. Mall, A. Wissner, T. Gonska, D. Calenborn, J. Kuehr, M. Brandis, and K. Kunzelmann Inhibition of Amiloride-Sensitive Epithelial Na+ Absorption by Extracellular Nucleotides in Human Normal and Cystic Fibrosis Airways Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 755 - 761. [Abstract] [Full Text]

				A. ZSEMBERY, M. STRAZZABOSCO, and J. GRAF Ca2+-activated Cl- channels can substitute for CFTR in stimulation of pancreatic duct bicarbonate secretion FASEB J, November 1, 2000; 14(14): 2345 - 2356. [Abstract] [Full Text]

				G.P.H. Leung and P.Y.D. Wong Activation of Cystic Fibrosis Transmembrane Conductance Regulator in Rat Epididymal Epithelium by Genistein Biol Reprod, January 1, 2000; 62(1): 143 - 149. [Abstract] [Full Text]

				A. Saleh, C. Figarella, W. Kammouni, S. Marchand-Pinatel, A. Lazdunski, A. Tubul, P. Brun, and M. D. Merten Pseudomonas aeruginosa Quorum-Sensing Signal Molecule N-(3-Oxododecanoyl)-L-Homoserine Lactone Inhibits Expression of P2Y Receptors in Cystic Fibrosis Tracheal Gland Cells Infect. Immun., October 1, 1999; 67(10): 5076 - 5082. [Abstract] [Full Text] [PDF]

				P. G. NOONE, W. D. BENNETT, J. A. REGNIS, K. L. ZEMAN, J. L. CARSON, M. KING, R. C. BOUCHER, and M. R. KNOWLES Effect of Aerosolized Uridine-5'-Triphosphate on Airway Clearance with Cough in Patients with Primary Ciliary Dyskinesia Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 144 - 149. [Abstract] [Full Text]

				L. L. Clarke, M. C. Harline, M. A. Otero, G. G. Glover, R. C. Garrad, B. Krugh, N. M. Walker, F. A. Gonzalez, J. T. Turner, and G. A. Weisman Desensitization of P2Y2 receptor-activated transepithelial anion secretion Am J Physiol Cell Physiol, April 1, 1999; 276(4): C777 - C787. [Abstract] [Full Text] [PDF]

				D. C. Devor and J. M. Pilewski UTP inhibits Na+ absorption in wild-type and Delta F508 CFTR-expressing human bronchial epithelia Am J Physiol Cell Physiol, April 1, 1999; 276(4): C827 - C837. [Abstract] [Full Text] [PDF]

				E. M. Schwiebert ABC transporter-facilitated ATP conductive transport Am J Physiol Cell Physiol, January 1, 1999; 276(1): C1 - C8. [Abstract] [Full Text] [PDF]

				E. M. SCHWIEBERT, D. J. BENOS, M. E. EGAN, M. J. STUTTS, and W. B. GUGGINO CFTR Is a Conductance Regulator as well as a Chloride Channel Physiol Rev, January 1, 1999; 79(1): 145 - 166. [Abstract] [Full Text] [PDF]

				J. M. PILEWSKI and R. A. FRIZZELL Role of CFTR in Airway Disease Physiol Rev, January 1, 1999; 79(1): 215 - 255. [Abstract] [Full Text] [PDF]

				T. D. Nguyen, M. W. Moody, C. E. Savard, and S. P. Lee Secretory effects of ATP on nontransformed dog pancreatic duct epithelial cells Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G104 - G113. [Abstract] [Full Text] [PDF]

				T. HOFMANN, M. J. STUTTS, A. ZIERSCH, C. RUCKES, W. M. WEBER, M. R. KNOWLES, H. LINDEMANN, and R. C. BOUCHER Effects of Topically Delivered Benzamil and Amiloride on Nasal Potential Difference in Cystic Fibrosis Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1844 - 1849. [Abstract] [Full Text] [PDF]

				S. L. Winters and D. B. Yeates Interaction between ion transporters and the mucociliary transport system in dog and baboon J Appl Physiol, October 1, 1997; 83(4): 1348 - 1359. [Abstract] [Full Text] [PDF]

				R. C. Stern The Diagnosis of Cystic Fibrosis N. Engl. J. Med., February 13, 1997; 336(7): 487 - 491. [Full Text] [PDF]

				M. A. Carew, X. Yang, C. Schultz, and S. B. Shears myo-Inositol 3,4,5,6-Tetrakisphosphate Inhibits an Apical Calcium-activated Chloride Conductance in Polarized Monolayers of a Cystic Fibrosis Cell Line J. Biol. Chem., August 25, 2000; 275(35): 26906 - 26913. [Abstract] [Full Text] [PDF]

				M. W. Y. Ho, M. A. Kaetzel, D. L. Armstrong, and S. B. Shears Regulation of a Human Chloride Channel. A PARADIGM FOR INTEGRATING INPUT FROM CALCIUM, TYPE II CALMODULIN-DEPENDENT PROTEIN KINASE, AND INOSITOL 3,4,5,6-TETRAKISPHOSPHATE J. Biol. Chem., May 25, 2001; 276(22): 18673 - 18680. [Abstract] [Full Text] [PDF]

				Y. Song and A. S. Verkman Aquaporin-5 Dependent Fluid Secretion in Airway Submucosal Glands J. Biol. Chem., October 26, 2001; 276(44): 41288 - 41292. [Abstract] [Full Text] [PDF]